Minnesota FOIA #P009988001

Minnesota Partnership for Biotechnology – Manipulating natural killer cell signaling to enhance immunotherapy.

This purchase order, issued by Twin Cities, Minnesota, on March 19, 2022, is a single-transaction award for the Mayo Clinic, located in Minneapolis, Minnesota, USA. The contract, valued at $499,340, funds research titled 'Minnesota Partnership for Biotechnology – Manipulating natural killer cell signaling to enhance immunotherapy.' The award involves a direct procurement of research services from Mayo Clinic, with no specific contract duration mentioned. The primary vendor is Mayo Clinic, with the award categorized under the state government sector. The award is part of a biomedical research initiative, and the procurement likely involves specialized biotech equipment or services related to immunotherapy research.

Description

Minnesota Partnership for Biotechnology – Manipulating natural killer cell signaling to enhance immunotherapy.